Peroxisome Proliferator-Activated Receptor (PPAR) γ and PPARα Agonists Modulate Mitochondrial Fusion-Fission Dynamics: Relevance to Reactive Oxygen Species (ROS)-Related Neurodegenerative Disorders?

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Zolezzi, Juan M ^a   Silva Alvarez, Carmen ^b   Ordenes, Daniela ^b   Godoy, Juan A ^b   Carvajal, Francisco J ^b   Santos, Manuel J ^b   Inestrosa, Nibaldo C ^b  

^a UNIVERSIDAD DE TARAPACÁ   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CIGLITAZONE; DYNAMIN RELATED PROTEIN 1; HYDROGEN PEROXIDE; MITOCHONDRIAL FISSION PROTEIN 1; MITOCHONDRIAL PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PIRINIXIC ACID; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; WAY 14 643; 2,4 THIAZOLIDINEDIONE DERIVATIVE; DRP1 PROTEIN, RAT; DYNAMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PPARGC1A PROTEIN, RAT; PYRIMIDINE DERIVATIVE; TRANSCRIPTION FACTOR; TTC11 PROTEIN, RAT;

ANIMAL CELL; ARTICLE; BRAIN MITOCHONDRION; BRAIN NERVE CELL; CONTROLLED STUDY; DEGENERATIVE DISEASE; EMBRYO; HIPPOCAMPUS; IMMUNOFLUORESCENCE; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL FISSION; MITOCHONDRIAL FUSION; MITOCHONDRIAL VOLUME; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT; ANIMAL; ANIMAL EMBRYO; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MITOCHONDRION; NERVE CELL; PRIMARY CELL CULTURE; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE; AGONISTS; DRUG EFFECTS;

ANIMALS; DYNAMINS; EMBRYO, MAMMALIAN; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MITOCHONDRIA; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL PROTEINS; NEURONS; OXIDATIVE STRESS; PPAR ALPHA; PPAR GAMMA; PRIMARY CELL CULTURE; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS;

EID: 84877654967     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064019     Document Type: Article

References (58)

1. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, et al. (2011) Alzheimer's disease. Lancet 377: 1019-1031.
2. Perl DP, (2010) Neuropathology of Alzheimer's disease. Mt Sinai J Med 77: 32-42.
3. Querfurth HW, LaFerla FM, (2010) Alzheimer's disease. N Engl J Med 362: 329-344.
4. Cramer PE, Cirrito JR, Wesson DW, Lee CY, Karlo JC, et al. (2012) ApoE-directed therapeutics rapidly clear β.amyloid and reverse deficits in AD mouse models. Science 335: 1503-1506.
5. Food and Drug Administration (FDA) website. Available: http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/21055_Targretin.cfm. Accessed 2012 Dec 28.
6. European Medicines Agency (EMA) website. Available: http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/000326/WC500034208.pdf. Accessed 2013 Dec 28.
7. LaFerla FM, (2012) Preclinical success against Alzheimer's disease with an old drug. N Engl J Med 367: 570-574.
8. Bachmeier C, Beaulieu-Abdelahad D, Crawford F, Mullan M, Paris D (2012) Stimulation of the Retinoid X Receptor facilitates β-amyloid clearance across the blood-brain barrier. J Mol Neurosci PMID: 22890420.
9. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, et al. (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the mayor correlate of cognitive impairment. Ann Neurol 30: 572-580.
10. Manji H, Kato T, Di Prospero NA, Ness S, Beal MF, et al. (2012) Impaired mitochondrial function in psychiatric disorders. Nature Rev Neurosci 13: 293-307.
11. Haass C, Selkoe DJ, (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide. Nat Rev Mol Cell Biol 8: 101-112.
12. Paula-Lima AC, Adasme T, SanMartín C, Sebollela A, Hetz C, et al. (2011) Amyloid β-peptide oligomers stimulate RyR-mediated Ca2+ reléase inducing mitocondrial fragmentation in hippocampal neurons and prevent RyR-mediated dendritic spine remodeling produced by BDNF. Antioxid Redox Signal 14: 1209-1223.
13. Cavalluci V, D'Amelio M, Cecconi F, (2012) Aβ toxicity in Alzheimer's disease. Mol Neurobiol 45: 366-378.
14. Caspersen C, Wang N, Yao J, Sosunov A, Chen X, et al. (2005) Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J 19: 2040-2041.
15. Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, et al. (2006) Mitochondria are direct site of Aβ accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 15: 1437-1449.
16. Reddy PH, Beal MF, (2008) Amyloid β, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol Med 14: 45-53.
17. Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, et al. (1996) Oxidative damage in Alzheimer's. Nature 382: 120-121.
18. Abramov AY, Canevari L, Duchen MR, (2004) β-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J Neurosci 24: 565-575.
19. Itoh K, Nakamura K, Iijima M, Sesaki H (2012) Mitochondrial dynamics in neurodegeneration. Trends Cell Biol doi: 10.1016/j.tcb.2012.10.006.
20. Inestrosa NC, Godoy JA, Quintanilla RA, Koenig CS, Bronfman M, (2005) Peroxisome proliferator-activated receptor gamma is expressed in hippocampal neurons and its activation prevents β-amyloid neurodegeneration: role of Wnt signaling. Exp Cell Res 304: 91-104.
21. Santos MJ, Quintanilla RA, Toro A, Grandy R, Dinamarca MC, et al. (2005) Peroxisomal proliferation protects from beta-amyloid neurodegeneration. J Biol Chem 280: 41057-41068.
22. Fuenzalida K, Quintanilla R, Ramos P, Piderit D, Fuentealba RA, et al. (2007) Peroxisome proliferator-activated receptor γ up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis. J Biol Chem 282: 37006-37015.
23. Toledo EM, Inestrosa NC, (2010) Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease. Mol Psychiatry 15: 272-285.
24. Inestrosa NC, Carvajal FJ, Zolezzi JM, Tapia-Rojas C, Serrano F, et al. (2012) Peroxisome proliferators reduce spatial memory impairment, synaptic failure, and neurodegeneration in brains of a double transgenic mice model of Alzheimer's disease. J Alzheimers Dis doi: 10.3233/JAD-2012-120397.
25. Mulholland DJ, Dedhar S, Coetzee GA, Nelson CC, (2005) Interaction of Nuclear Receptors with the Wnt/β-catenin/Tcf signaling axis: Wnt you like to know?. Endocr Rev 26: 898-915.
26. Delerive P, Wu Y, Burris TP, Chin WW, Suen CS, (2002) PGC-1 functions as a transcriptional coactivator for the retinoid X receptors. J Biol Chem 277: 3913-3917.
27. Qin W, Haroutunian V, Kastel P, Cardozo CP, Ho L, et al. (2009) PGC-1α expression decreases in the Alzheimer disease brain as function of dementia. Arch Neurol 66: 352-361.
28. Wareski P, Vaarmann A, Choubey V, Safiulina D, Liiv J, et al. (2009) PGC-1α and PGC-1β regulate mitochondrial density in neurons. J Biol Chem 284: 21379-21385.
29. Dinamarca MC, Sagal JP, Quintanilla RA, Godoy JA, Arrázola MS, et al. (2010) Amyloid-β-acetylcholinesterase complexes potentiate neurodegenerative changes induced by the Abeta peptide. Implications for the pathogenesis of Alzheimer's disease. Mol Neurodegener 5: 4.
30. Nakamura K, Watakabe A, Hioki H, Fujiyama F, Tanaka Y, et al. (2007) Transiently increased colocalization of vesicular glutamate transporters 1 and 2 at single axon terminals during postnatal development of mouse neocortex: a quantitative analysis with correlation coefficient. Eur J Neurosci 26: 3054-3067.
31. Anderson RM, Barger JL, Edwards MG, Braun KH, O'Connor CE, et al. (2008) Dynamic regulation of PGC-1α localization and turnover implicates mitochondrial adaptation in calorie restriction and the stress response. Aging Cell 7: 101-111.
32. Puigserver P, Spiegelman BM, (2003) Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α): transcriptional coactivator and metabolic regulator. Endocr Rev 24: 78-90.
33. Elgass K, Pakay J, Ryan MT, Palmer CS, (2012) Recent advances into understanding of mitochondrial fission. Biochim Biophys Acta 1833: 150-161.
34. Westermann B, (2010) Mitochondrial fusion and fission in cell life and death. Nat Rev Mol Cell Biol 11: 872-884.
35. Sabatier N, Richard P, Dayanithi G, (1998) Activation of multiple intracellular transduction signals by vasopressin in vasopressin-sensitive neurons of the rat supraoptic nucleus. J Physiol 513 (3):: 699-710.
36. Han X-J, Lu Y-F, Li S-A, Kaitsuka T, Sato Y, et al. (2008) CaM kinase Iα-induced phosphorylation of Drp1 regulates mitochondrial morphology. J Cell Biol 182: 573-585.
37. Balaban RS, Nemoto S, Finkel T, (2005) Mitochondria, oxidants, and aging. Cell 120: 483-495.
38. Chen H, Vermulst M, Wang YE, Chomyn A, Prolla TA, et al. (2010) Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell 141: 280-289.
39. Puigserver P, Wu Z, Park CW, Graves R, Wright M, et al. (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92: 829-839.
40. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, et al. (1999) Mechanism controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98: 115-124.
41. Liesa M, Palacín M, Zorzano A, (2009) Mitochondrial dynamics in mammalian health and disease. Physiol Rev 89: 799-845.
42. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, et al. (2006) Supression of reactive oxygen species and neurodegeneration by the PGC-1α transcriptional coactivators. Cell 127: 397-408.
43. Mates JM, Perez-Gomez C, Nunez de Castro I, (1999) Antioxidant enzymes and human diseases. Clin Biochem 32: 595-603.
44. Austin S, Klimcakova E, St-Pierre J, (2011) Impact of PGC-1α on the topology aand rate of superoxide production by the mitochondrial electron transport chain. Free Radic Biol Med 51: 2243-2248.
45. Vamecq J, Latruffe N, (1999) Medical significance of peroxisome proliferator-activated receptors. Lancet 354: 141-148.
46. Feilchenfeldt J, Bründler MA, Soravia C, Tötsch M, Meier CA, (2004) Peroxisome proliferator-activated receptors (PPARs) and associated transcription factors in colon cancer: reduced expression of PPARγ-coactivator 1 (PGC-1). Cancer Letters 203: 25-33.
47. Mysiorek C, Culot M, Dehouck L, Derudas B, Staels B, et al. (2009) Peroxisome proliferator-activated receptor-α activation protects brain capillary endothelial cells from oxygen-glucose deprivation-induced hyperpermeability in the blood-brain barrier. Curr Neurovasc Res 6: 181-193.
48. Lalloyer F, Staels B, (2010) Fibrates, glitazones, and peroxisome proliferator-activated receptors. Arterioscler Thromb Vasc Biol 30: 894-899).
49. Ricobaraza A, Cuadrado-Tejedor M, Marco S, Pérez-Otaño I, García-Osta A (2010) Phanylbutyrate rescues dendritic spine loss associated with memory déficits in mouse model of Alzheimer disease. Hippocampus doi:10.1002/hipo.20883.
50. Diano S, Liu ZW, Jeong JK, Dietrich MO, Ruan HB, et al. (2011) Peroxisome proliferation-associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity. Nat Med 17: 1121-1127.
51. Haemmerle G, Moustafa T, Woelkart G, Büttner S, Schmidt A, et al. (2011) ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1. Nat Med 17: 1076-1085.
52. Hondares E, Rosell M, Díaz-Delfin J, Olmos Y, Monsalve M, et al. (2011) Peroxisome proliferator-activated receptor α (PPARα) induces PPARγ coactivator 1α (PGC-1α) gene expression and contributes to thermogenic activation of brown fat. J Biol. Chem. 286: 43112-43122.
53. De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, et al. (2007) Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 282: 11590-11601.
54. Pancani T, Phelps JT, Searcy JL, Kilgore MW, Chen K-C, et al. (2009) Distinct modulation of voltage-gated and ligand-gated Ca2+ currents by PPAR-γ agonists in cultured hippocampal neurons. J Neurochem 109: 1800-1811.
55. Khasabova IA, Xiong Y, Coicou LG, Piomelli D, Seybold V, (2012) Peroxisome proliferator-activated receptor α mediates acute effects of palmitoylethaanolamide on sensory neurons. J Neurosci 32: 12735-12743.
56. Peraza MA, Burdick AD, Marin HE, Gonzales FJ, Peters JM, (2005) The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR). Toxicol Sci 90: 269-295.
57. Lonard DM, O'Malley BW, (2007) Nuclear receptor coregulators: judges, juries and executioners of cellular regulation. Mol Cell 27: 691-700.
58. Quintanilla RA, Muñoz FJ, Metcalfe MJ, Hitschfeld M, Olivares G, et al. (2005) Trolox and 17β-estradiol protect against β-peptide neurotoxicity by a mechanism that involves modulation of the Wnt signaling pathway. J Biol Chem 280: 11615-11625.